Drugs that are bioequivalent release the active ingredient into the bloodstream at virtually the same rate and in virtually the same amount as the original drug it is designed to mimic. The purpose of bioequivalence studies is to prove that:
The generic version contains the identical inactive ingredients as the brand-name drug
The generic version is as effective as the brand-name drug
The generic version is as safe as the brand-name drug
The generic version releases its drug at virtually the same speed and in the same amounts as the brand-name drug
